Skip to main content

Table 4 Clinical data of patients with pathogenic germline mutations and co-occurring mutations

From: Germline mutations among Polish patients with acute myeloid leukemia

Patient laboratory number

Sex/age

AML classification

(FAB)

Karyotype

Family history of cancer

Nucleotide change

IDH2

CEBPA

GATA2

ETV6

TERT

DDX41

10

M/44

M5

NK

ND

c.419G > A*

c.709 C > A

c.1018-19 C > T

c.1770-24 C > T

c.3184G > A

c.936-23 C > G

c.1200 C > T

13

K/47

M1

NK

CLL60

c.590_591insACCCGC*

c.1075 C > A*

c.936-23 C > G

c.1200 C > T

33

K/37

M6

NK

ND

c.337_344del*

c.258G > A

c.915G > A

c.409 A > G

c.936-23 C > G

c.1200 C > T

43

M/20

M1

NK

ND

c.590_591insACCCGC*

c.490G > A

c.463 + 49G > A

c.409 A > G

c.936-23 C > G

c.1200 C > T

47

M/51

M4

NK

Pr72, Ut70

c.590_591insACCCGC*

c.258G > A

c.936-23 C > G

c.1200 C > T

83

K/49

M4

t(9;11)

Br50

c.590_591insACCCGC*

c.15 C > G

c.490G > A

c.936-23 C > G

97

M/48

M1

NK

Bn62

c.419G > A*

c.690G > T

c.15 C > G

c.936-23 C > G

  1. CLL - chronic lymphocytic leukemia, Pr - prostate cancer, Ut - uterine cancer, Br - breast cancer, Bn - brain cancer, FAB - French-American-British classification, (*) - germline mutation, NK - normal karyotype, ND - no data, (–) - no mutation